Key Metrics
9.7
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.88
5-Year SI
5-year SI
- N/A 2-year SI
- 0.87 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Hematology
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.75
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
28%
4 to 6 months
45%
7 to 9 months
19%
Above 9 months
8%
Did you find this useful?
Thank you for your feedback.
Topics Covered
- Cancer
- Lung cancer
- Reactive oxygen species
- Antigen
- Cisplatin
- Immunotherapy
- Breast cancer
- Glucocorticoid
- Immune checkpoint inhibitors
- Hepatocellular carcinoma
- Quality of life
- Chemoradiotherapy
- Carcinogenesis
- Overall survival
- Confidence interval
- Epidermal growth factor receptor
- Toxicity
- Ovarian cancer
- Meta-analysis
- Oxidative stress
Journal Specifications
| Overview | |
| Publisher | ELSEVIER SCIENCE INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1989 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Critical Reviews in Oncology/Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Efficacy and safety of PD-1/PD-L1 inhibitors combined with standard of care for locally advanced head and neck squamous cell carcinoma: A meta-analysis of randomized controlled trials.
- 1 May 25
- Critical reviews in oncology/hematology
-
Full paper
Meta-Analysis of Clinical Trial on the Comparative Efficacy and Safety Profiles of Immunotherapeutic Strategies in Cervical Cancer.
- 1 May 25
- Critical reviews in oncology/hematology
-
Full paper
Chimeric antigen receptor T cell immunotherapy for gynecological malignancies.
- 1 May 25
- Critical reviews in oncology/hematology
-
Full paper
PERSONALIZED MEDICINE IN ORAL CANCER.
- 1 May 25
- Critical reviews in oncology/hematology
-
Full paper
Immunotherapy in OSCC: Current trend and challenges.
- 1 May 25
- Critical reviews in oncology/hematology
-
Full paper
Predictors of prognosis and overall survival in pediatric mucoepidermoid carcinoma of salivary glands: A systematic review.
- 1 May 25
- Critical reviews in oncology/hematology
Scite analysis
Powered by scite_
5.1k articles received 123.7k citations see all
- 2,832 Supporting
- 115,917 Mentioning
- 422 Contrasting
Editorial notices
- 0 Retractions
- 4 Withdrawals
- 1 Corrections
- 25 Errata
- 0 Expression of Concern
FAQs
How long has Critical Reviews in Oncology/Hematology been actively publishing?
Critical Reviews in Oncology/Hematology has been in operation since 1989 till date.
What is the publishing frequency of Critical Reviews in Oncology/Hematology ?
Critical Reviews in Oncology/Hematology published with a Monthly frequency.
How many articles did Critical Reviews in Oncology/Hematology publish last years ?
In 2024, Critical Reviews in Oncology/Hematology published 250 articles.
What is the eISSN & pISSN for Critical Reviews in Oncology/Hematology ?
For Critical Reviews in Oncology/Hematology,eISSN is 1879-0461 and pISSN is1040-8428.
What is Citescore for Critical Reviews in Oncology/Hematology ?
Citescore for Critical Reviews in Oncology/Hematology is 9.7.
What is SNIP score for Critical Reviews in Oncology/Hematology ?
SNIP score for Critical Reviews in Oncology/Hematology is 1.75.
What is the SJR for Critical Reviews in Oncology/Hematology ?
SJR for Critical Reviews in Oncology/Hematology is Q1.
Who is the publisher of Critical Reviews in Oncology/Hematology ?
ELSEVIER SCIENCE INC is the publisher of Critical Reviews in Oncology/Hematology.